HPQ
39
2
DD
40
6
BLK
66
3
HPE
27
4
APD
44
2
BAC
57
3
FIS
77
2
ROK
35
-4
JBHT
40
5
CA
13
-6
A
43
2
NKE
21
-2
AIV
43
2
CME
59
-2
BK
72
4
GWW
60
7
CFG
62
2
FLR
52
3
FE
52
-8
HST
37
5
HPQ
39
2
DD
40
6
BLK
66
3
HPE
27
4
APD
44
2
BAC
57
3
FIS
77
2
ROK
35
-4
JBHT
40
5
CA
13
-6
A
43
2
NKE
21
-2
AIV
43
2
CME
59
-2
BK
72
4
GWW
60
7
CFG
62
2
FLR
52
3
FE
52
-8
HST
37
5
Financhill
Back

Stellantis NV Vs. Alnylam Pharmaceuticals Industry Stock Comparison

Sell
30

STLA
Stellantis NV

Last Price:
$12.28
Seasonality Move:
-3.96%
Buy
60

ALNY
Alnylam Pharmaceuticals

Last Price:
$290.61
Seasonality Move:
3.3%
Sell
30
Stellantis NV (STLA) is a Sell

Is Stellantis NV a Buy, Sell or Hold?

  • The current Stellantis NV [STLA] share price is $12.28. The Score for STLA is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • STLA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
60
Alnylam Pharmaceuticals (ALNY) is a Buy

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $290.70. The Score for ALNY is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • ALNY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

STLA Stock Price Chart

What is Stellantis NV's stock price today?

  • The Stellantis NV share price today is $12.28
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and STLA is experiencing buying pressure, which is a positive indicator for future bullish movement.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $290.70
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing selling pressure, which indicates risk of future bearish movement.

STLA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.24 Sell
Relative Strength Index (14 RSI): 44.29 Sell
Chaikin Money Flow: 7976317 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (12.14 - 13.64) Sell
Bollinger Bands (100): (12.57 - 13.63) Sell

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.72 Buy
Relative Strength Index (14 RSI): 71.41 Buy
Chaikin Money Flow: -979016 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (238.44 - 263) Buy
Bollinger Bands (100): (240.32 - 271.8) Buy

STLA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 12.33 Sell
20-day SMA: 12.62 Sell
50-day SMA: 12.95 Sell
200-day SMA: 15.16 Sell
8-day EMA: 12.35 Sell
20-day EMA: 12.59 Sell
50-day EMA: 12.89 Sell
200-day EMA: 15.13 Sell

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 257.74 Buy
20-day SMA: 249.75 Buy
50-day SMA: 257.54 Buy
200-day SMA: 251.5 Buy
8-day EMA: 263.89 Buy
20-day EMA: 256.08 Buy
50-day EMA: 255.39 Buy
200-day EMA: 243.44 Buy

Stellantis NV Earnings Growth & STLA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.43 per share, and an increase next year of $0.67 per share.

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.91 per share, an increase next quarter of $0.05 per share, an increase this year of $1.08 per share, and an increase next year of $2.75 per share.

Stellantis NV Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):